InvestorsHub Logo
Followers 829
Posts 119605
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Thursday, 06/25/2020 1:09:32 PM

Thursday, June 25, 2020 1:09:32 PM

Post# of 867
FDA approves Keytruda monotherapy in cSCC:

https://www.businesswire.com/news/home/20200624005845/en

This approval is based on ORR and duration of response in a single-arm phase-2 trial, but it's a full-fledged approval rather than an accelerated approval.

The only other PD-(L)1 drug approved in this indication is SNY/REGN’s Libtayo (#msg-143876588).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News